Research Article| Volume 17, ISSUE 1, P51-62, July 1993

Hormonal treatments modulate pulsatile plasma growth hormone, gonadotrophin and osteocalcin levels in postmenopausal women

      This paper is only available as a PDF. To read, Please Download here.


      Oestrogen plays a role in modulating growth hormone (GH), luteinizing hormone (LH), folliclestimulating hormone (FSH) and osteocalcin secretion in women. Indeed, the postmenopausal period is characterized by changes in plasma GH, LH, FSH and osteocalcin levels. The aim of the present study was to investigate the changes in the secretory patterns of these hormones in postmenopausal women under different therapeutic regimens. A total of 20 subjects took part in the study. They were subdivided into four groups comprising 5 untreated postmenopausal women (time since menopause 1–5 years), 5 postmenopausal women receiving steroid hormone replacement therapy, 5 postmenopausal women receiving salmon calcitonin and 5 fertile women with regular menstrual cycles. Blood samples were collected every 15 min for 4 h and hormone levels were measured by radioimmunoassay. Plasma GH levels fell in the postmenopausal women, but were restored under oestrogen-progestogen treatment. The pulsatile patterns of plasma LH and FSH did not show significant differences in the treated and untreated women. Plasma osteocalcin levels showed episodic fluctuations and mean levels decreased under steroid hormone or calcitonin treatment. No significant correlation was observed between plasma GH and osteocalcin or gonadotrophin levels or body mass index.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Maturitas
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Brenner PF
        The menopause.
        Western J Med. 1982; 136: 211-219
        • Lauritzen C
        The hypothalamic anterior pituitary system in the climacteric age period.
        in: Van Keep PA Lauritzen C Frontiers in hormone research. Karger, Basel1975: 20-29
        • Yen SSC
        The biology of menopause.
        J Reprod Med. 1977; 18: 287-296
        • Chakravarti S
        • Collins WP
        • Forecast JD
        • Newton JR
        • Oram DH
        • Studd JWW
        Hormonal profiles after the menopause.
        Br Med J. 1976; ii: 784-786
        • Studd JWW
        • Collins WP
        • Chakravarti S
        Plasma hormone profiles after the menopause and bilateral oophorectomy.
        Postgrad Med J. 1978; 54: 25-30
        • Vale W
        • Rivier C
        • Hsueh A
        • Campen C
        • Meunier H
        • Bicsak T
        • Vaughan J
        • Corrigan A
        • Bardin W
        • Sawchenko P
        • Petraglia F
        • Yu J
        • Plotsky P
        • Spiess J
        • Rivier J
        Chemical and biological characterization of the inhibin family of protein hormones.
        Rec Prog Horm Res. 1988; 44: 1-32
        • Crilly RG
        • Francis RM
        • Nordin BEC
        Steroid hormones, ageing and bone.
        Clin Endocrinol Metab. 1981; 10: 115-139
        • Chang RJ
        • Judd HL
        The ovary after the menopause.
        Clin Obstet Gynecol. 1981; 24: 181-191
        • Bellantoni MF
        • Harman MS
        • Cho DE
        • Blackman MR
        Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages.
        J Clin Endocrinol Metab. 1991; 72: 172-178
        • Dawson-Hughes B
        • Stern D
        • Goldman J
        • Reichlin S
        Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: effect of physiological estrogen replacement.
        J Clin Endocrinol Metab. 1986; 63: 424-432
        • Copeland KC
        • Johnson DM
        • Kuehl TJ
        • Castracane VD
        Estrogen stimulates growth hormone and somatomedin-C in castrate and intact female baboons.
        J Clin Endocrinol Metab. 1984; 58: 698-703
        • Thompson RG
        • Rodriguez A
        • Kowarski A
        • Blizzard RM
        Growth hormone: metabolic clearance rates, integrated concentrations and production rates in normal adults and the effect of prednisone.
        J Clin Invest. 1972; 51: 3193-3199
        • Ho KY
        • Evans WS
        • Blizzard RM
        Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol2 concentrations.
        J Clin Endocrinol Metab. 1987; 64: 51-58
        • Franchimont P
        • Urbain-Choffray D
        • Lambelin P
        • Fontaine MA
        • Frangin G
        • Reginster JY
        Effect of repetitive administration of growth hormone-releasing hormone on growth hormone secretion, insulin-like growth factor I, and bone metabolism in postmenopausal women.
        Acta Endocrinol. 1989; 120: 121-128
        • Weissberger AJ
        • Ho KKY
        • Lazarus L
        Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone secretion, insulin-like growth factor I and GH-binding protein in postmenopausal women.
        J Clin Endocrinol Metab. 1991; 72: 374-381
        • Duursma SA
        • Bijlsma JWJ
        • van Paassen HC
        • Slootweg MC
        Oestrogens and bone metabolism: a hypothesis.
        Maturitas. 1986; 8: 1-6
        • Wiedemann E
        • Schwarts E
        • Frantz AG
        Acute and chronic estrogen effects upon serum somatomedin activity, growth hormone and prolactin in man.
        J Clin Endocrinol Metab. 1976; 42: 942-952
        • Hock JM
        • Centrella M
        • Canalis E
        Insulin-like growth factor I has independent effects on bone matrix formation and cell replication.
        Endocrinology. 1988; 122: 254-260
        • Sidenius Johansen J
        • Giwercman A
        • Hartwell D
        • Thoger Nielsen C
        • Price PA
        • Christiansen C
        • Skakkebaek NE
        Serum bone gla-protein as marker of bone growth in children and adolescents: correlation with age, height, serum insulin-like growth factor I and serum testosterone.
        J Clin Endocrinol Metab. 1988; 67: 273-278
        • Nelson ME
        • Meredith CN
        • Dawson-Hughes B
        • Evans WJ
        Hormone and bone mineral status in enduranee-trained and sedentary postmenopausal women.
        J Clin Endocrinol Metab. 1988; 66: 927-933
        • Mazess RB
        • Barden HS
        • Hanson JA
        Precision of DPA with 153Gd.
        in: Abstract 225, presented at the tenth annual meeting of the American Society of Bone Mineral Research, New Orleans1988
        • Oerter KE
        • Guardobasso V
        • Robard D
        Detection and characterization of peaks and estimation of instantaneous secretory rate for episodic pulsatile hormone secretion.
        Comp Biomed Res. 1986; 19: 170-191
        • Rudman D
        • Kutner MH
        • Rogers CM
        • Lubin MF
        • Fleming GA
        • Bain RP
        Impaired growth hormone secretion in the adult population: relation to age and adiposity.
        J Clin Invest. 1981; 67: 1361-1369
        • Zadik Z
        • Chalew SA
        • MacCarter RJ
        • Meistas M
        • Kowarski AA
        The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals.
        J Clin Endocrinol Metab. 1985; 60: 513-516
        • Vermeulen A
        Nyctohemeral growth hormone profiles in young and aged man: correlation with somatomedin-C levels.
        J Clin Endocrinol Metab. 1987; 64: 51-58
        • Fröhlander N
        • von Schoultz B
        Growth hormone and somatomedin C during postmenopausal replacement therapy with oestrogen alone and in combination with an anti-oestrogen.
        Maturitas. 1988; 9: 297-302
        • Shirasu K
        • Stumpf WE
        • Sar M
        Evidence for direct action of estradiol on growth hormone-releasing factor (GRF) in rat hypothalamus: localization of [3H] estradiol in GRF neurons.
        Endocrinology. 1990; 127: 344-349
        • Stumpf WE
        • Sar M
        • Reisert I
        • Pilgrim C.
        Estrogen receptor sites in the developing central nervous system and their relationship to catecholamine systems.
        Monogr Neural Sci. 1983; 9: 205
        • Martin JB
        Neural regulation of growth hormone secretion.
        in: Medical progress report. 2nd edn. N Engl J Med. 228. 1973: 1384
        • Locatelli V
        Neuroregulation of growth hormone secretion.
        in: Genazzani AR Petraglia F Volpe A Progress in gynecology and obstetrics. Parthenon Publishing Group, Park Ridge1990: 449-454
        • Bethea CL
        Estrogen action on growth hormone in pituitary cell cultures from adult and juvenile macaques.
        Endocrinology. 1991; 129: 2110-2118
        • Berelowitz M
        • Szabo M
        • Frohman LA
        • Firestone S
        • Chu L
        • Hintz RL
        Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary.
        Science. 1981; 221: 1279
        • Cagnacci A
        • Melis GB
        • Paoletti AM
        • Gambacciani M
        • Soldani R
        • Spinetti A
        • Fioretti P
        Influence of oestradiol and progesterone on pulsatile LH secretion in postmenopausal women.
        Clin Endocrinol. 1989; 31: 541-550
        • Veldhuis JD
        • Evans WS
        • Rogol AD
        • Thorner MO
        • Stumpf P
        Actions of estradiol on discrete attributes of the luteinizing hormone pulse signal in man.
        in: Studies in postmenopausal women treated with pure estradiol. 2nd edn. J Clin Invest. 79. 1987: 769-776
        • McNeilly AS
        The control of FSH secretion.
        Acta Endocrinol. 1988; 288: 31-40
        • Gundberg CM
        • Markowitz ME
        • Mizruchi M
        • Rosen JF
        Osteocalcin in human serum: A circadian rhythm.
        J Clin Endocrinol Metab. 1985; 60: 736-739
        • Price PA
        • Williamson MK
        • Lothringer JW
        Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone.
        J Biol Chem. 1981; 256: 12760
        • Price PA
        • Baukol SA
        1,25 Dihydroxyvitamin D3 increases synthesis of the vitamin K-dependent bone protein by osteosarcoma cells.
        J Biol Chem. 1980; 255: 11660
        • Salomon F
        • Cuneo RC
        • Hesp R
        • Sonksen PH
        The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency.
        N Engl J Med. 1989; 321: 1797-1803
        • Aloia JF
        • Vaswani A
        • Meunier PJ
        Coherence treatment of postmenopausal osteoporosis with growth hormone and calcitonin.
        Calcif Tissue Int. 1987; 40: 253-259
        • Johansen JS
        • Riis BJ
        • Delmas PD
        • Christiansen C.
        Plasma BGP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women.
        Eur J Clin Invest. 1988; 18: 191-195
        • Podenphant J
        • Christiansen C
        • Catherwood BD
        • Deftos LJ
        Serum bone Gla protein variations during estrogen and calcium prophylaxis of postmenopausal women.
        Calcif Tissue Int. 1984; 36: 536-540
        • Christiansen C
        • Overgaard K
        • Riis BJ
        The optimum regimens for usage of intranasal salmon calcitonin and treatment of postmenopausal osteoporosis.
        in: 2nd edn. Osteoporosis. 3. 1990: 1888-1891